{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:49:09Z","timestamp":1789674549748,"version":"4.0.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T00:00:00Z","timestamp":1382054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T00:00:00Z","timestamp":1382054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s11910-013-0408-6","type":"journal-article","created":{"date-parts":[[2013,10,17]],"date-time":"2013-10-17T02:20:40Z","timestamp":1381976440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Joshua J.","family":"Chalkley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,18]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"KE Astrom","year":"1958","unstructured":"Astrom KE, Mancall EL, Richardson Jr EP. Progressive multifocal leuko-encephalopathy; a hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin's disease. Brain. 1958;81:93\u2013111.","journal-title":"Brain"},{"issue":"2","key":"408_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","volume":"2","author":"BR Brooks","year":"1984","unstructured":"Brooks BR, Walker DL. Progressive multifocal leukoencephalopathy. Neurol Clin. 1984;2(2):299\u2013313.","journal-title":"Neurol Clin"},{"key":"408_CR3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/archneur.1984.04050180102028","volume":"41","author":"C Bernick","year":"1984","unstructured":"Bernick C, Gregorios JB. Progressive multifocal leukoencephalopathy in a patient with acquired immune deficiency syndrome. Arch Neurol. 1984;41:780\u20132.","journal-title":"Arch Neurol"},{"key":"408_CR4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0733-8619(18)31106-X","volume":"2","author":"CB Britton","year":"1984","unstructured":"Britton CB, Miller JR. Neurologic complications in acquired immunodeficiency syndrome (AIDS). Neurol Clin. 1984;2:315\u201339.","journal-title":"Neurol Clin"},{"key":"408_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.410140404","volume":"14","author":"WD Snider","year":"1983","unstructured":"Snider WD et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol. 1983;14:403\u201318.","journal-title":"Ann Neurol"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.7326\/0003-4819-107-1-78","volume":"107","author":"JR Berger","year":"1987","unstructured":"Berger JR et al. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann Intern Med. 1987;107:78\u201387.","journal-title":"Ann Intern Med"},{"key":"408_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3109\/13550289809113482","volume":"4","author":"JR Berger","year":"1998","unstructured":"Berger JR et al. Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol. 1998;4:59\u201368.","journal-title":"J Neurovirol"},{"key":"408_CR8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"BK Kleinschmidt-DeMasters","year":"2005","unstructured":"Kleinschmidt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005;353:369\u201374.","journal-title":"N Engl J Med"},{"key":"408_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A Langer-Gould","year":"2005","unstructured":"Langer-Gould A et al. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005;353:375\u201381.","journal-title":"N Engl J Med"},{"key":"408_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"G Van Assche","year":"2005","unstructured":"Van Assche G et al. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med. 2005;353:362\u20138.","journal-title":"N Engl J Med"},{"key":"408_CR11","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2165\/11537510-000000000-00000","volume":"33","author":"JR Berger","year":"2010","unstructured":"Berger JR. Progressive multifocal leukoencephalopathy and newer biological agents. Drug Saf. 2010;33:969\u201383.","journal-title":"Drug Saf"},{"key":"408_CR12","first-page":"27","volume":"2","author":"M Bechtel","year":"2009","unstructured":"Bechtel M, Sanders C, Bechtel A. Neurological complications of biologic therapy in psoriasis: a review. J Clin Aesthet Dermatol. 2009;2:27\u201332.","journal-title":"J Clin Aesthet Dermatol"},{"issue":"12","key":"408_CR13","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/TP.0b013e3182007b95","volume":"90","author":"J Grinyo","year":"2010","unstructured":"Grinyo J, et al. An integrated safety profile analysis of belatacept in kidney transplant recipients. Transplantation. 2010;90(12):1521\u20137.","journal-title":"Transplantation"},{"key":"408_CR14","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1212\/WNL.0b013e3182749f17","volume":"79","author":"G von Geldern","year":"2012","unstructured":"von Geldern G et al. PML-IRIS in a patient treated with brentuximab. Neurology. 2012;79:2075\u20137.","journal-title":"Neurology"},{"issue":"11","key":"408_CR15","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3109\/10428194.2012.676170","volume":"53","author":"ND Wagner-Johnston","year":"2012","unstructured":"Wagner-Johnston ND, et al. Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin. Leuk Lymphoma. 2012;53(11):2283\u20136.","journal-title":"Leuk Lymphoma"},{"key":"408_CR16","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1097\/TP.0b013e31818b62c8","volume":"86","author":"RT Neff","year":"2008","unstructured":"Neff RT et al. Progressive multifocal leukoencephalopathy and use of mycophenolate mofetil after kidney transplantation. Transplantation. 2008;86:1474\u20138.","journal-title":"Transplantation"},{"key":"408_CR17","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(59)91774-X","volume":"2","author":"J Cavanaugh","year":"1959","unstructured":"Cavanaugh J et al. Cerebral dymyelination associated with disorders of the reticuloendothelial system. Lancet. 1959;2:524\u20139.","journal-title":"Lancet"},{"key":"408_CR18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/BF00686519","volume":"5","author":"L Silverman","year":"1965","unstructured":"Silverman L, Rubinstein LJ. Electron microscopic observations on a case of progressive multifocal leukoencephalopathy. Acta Neuropathol (Berl). 1965;5:215\u201324.","journal-title":"Acta Neuropathol (Berl)"},{"key":"408_CR19","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1126\/science.148.3676.1477","volume":"148","author":"G ZuRhein","year":"1965","unstructured":"ZuRhein G. Particles resembling papovavirions in human cerebral demyelinating disease. Science. 1965;148:1477\u20139.","journal-title":"Science"},{"key":"408_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/infdis\/127.4.467","volume":"127","author":"BL Padgett","year":"1973","unstructured":"Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973;127:467\u201370.","journal-title":"J Infect Dis"},{"key":"408_CR21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1097\/WCO.0b013e328346d2a3","volume":"24","author":"JR Berger","year":"2011","unstructured":"Berger JR. Modeling PML, pathogenesis. Curr Opin Neurol. 2011;24:262\u20137.","journal-title":"Curr Opin Neurol"},{"key":"408_CR22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380\u20133.","journal-title":"Science"},{"key":"408_CR23","first-page":"107","volume":"105","author":"BL Padgett","year":"1983","unstructured":"Padgett BL, Walker DL. Virologic and serologic studies of progressive multifocal leukoencephalopathy. Prog Clin Biol Res. 1983;105:107\u201317.","journal-title":"Prog Clin Biol Res"},{"key":"408_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ana.22128","volume":"68","author":"L Gorelik","year":"2010","unstructured":"Gorelik L et al. Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol. 2010;68:295\u2013303.","journal-title":"Ann Neurol"},{"key":"408_CR25","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/ana.22606","volume":"70","author":"C Bozic","year":"2011","unstructured":"Bozic C et al. Anti-John Cunningham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1. Ann Neurol. 2011;70:742\u201350.","journal-title":"Ann Neurol"},{"key":"408_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/jmv.21710","volume":"82","author":"A Matos","year":"2010","unstructured":"Matos A et al. Characterization of JC human polyomavirus infection in a Portuguese population. J Med Virol. 2010;82:494\u2013504.","journal-title":"J Med Virol"},{"key":"408_CR27","doi-asserted-by":"crossref","first-page":"9918","DOI":"10.1128\/JVI.72.12.9918-9923.1998","volume":"72","author":"MC Monaco","year":"1998","unstructured":"Monaco MC et al. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J Virol. 1998;72:9918\u201323.","journal-title":"J Virol"},{"issue":"1","key":"408_CR28","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1086\/504947","volume":"43","author":"JR Berger","year":"2006","unstructured":"Berger JR et al. JC virus detection in bodily fluids: Clues to transmission. Clin Infect Dis. 2006;43(1):e9-12.","journal-title":"Clin Infect Dis"},{"key":"408_CR29","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/jmv.20829","volume":"79","author":"A Rossi","year":"2007","unstructured":"Rossi A et al. Presence, quantitation and characterization of JC virus in the urine of Italian immunocompetent subjects. J Med Virol. 2007;79:408\u201312.","journal-title":"J Med Virol"},{"key":"408_CR30","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1080\/13550280260422758","volume":"8","author":"H Chang","year":"2002","unstructured":"Chang H et al. High incidence of JC viruria in JC-seropositive older individuals. J Neurovirol. 2002;8:447\u201351.","journal-title":"J Neurovirol"},{"issue":"Suppl. 1","key":"408_CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13550280390195306","volume":"9","author":"S Bofill-Mas","year":"2003","unstructured":"Bofill-Mas S, Girones R. Role of the environment in the transmission of JC virus. J Neurovirol. 2003;9 Suppl 1:54\u20138.","journal-title":"J Neurovirol"},{"key":"408_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0928-0197(95)00012-W","volume":"4","author":"WA Knowles","year":"1995","unstructured":"Knowles WA et al. The JC virus antibody response in serum and cerebrospinal fluid in progressive multifocal leucoencephalopathy. Clin Diagn Virol. 1995;4:183\u201394.","journal-title":"Clin Diagn Virol"},{"key":"408_CR33","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1097\/00002030-199208000-00012","volume":"6","author":"JR Berger","year":"1992","unstructured":"Berger JR et al. Progressive multifocal leukoencephalopathy in HIV-1-infected children. Aids. 1992;6:837\u201341.","journal-title":"Aids."},{"key":"408_CR34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13550280390241188","volume":"9","author":"CG Fedele","year":"2003","unstructured":"Fedele CG et al. Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy. J Neurovirol. 2003;9:551\u20138.","journal-title":"J Neurovirol"},{"key":"408_CR35","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1056\/NEJMp0906248","volume":"361","author":"EO Major","year":"2009","unstructured":"Major EO. Reemergence of PML in natalizumab-treated patients\u2013new cases, same concerns. N Engl J Med. 2009;361:1041\u20133.","journal-title":"N Engl J Med"},{"key":"408_CR36","unstructured":"BiogenIdec. PML incidence in patients receiving Tysabri (natalizumab). Medical information 2013. Available at: http:\/\/medinfo.biogenidec.com (accessed 8 August 2013)."},{"key":"408_CR37","first-page":"495","volume":"12","author":"JR Berger","year":"2012","unstructured":"Berger JR, Khalili K. The pathogenesis of progressive multifocal leukoencephalopathy. Discov Med. 2012;12:495\u2013503.","journal-title":"Discov Med"},{"key":"408_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJM198802043180507","volume":"318","author":"SA Houff","year":"1988","unstructured":"Houff SA et al. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med. 1988;318:301\u20135.","journal-title":"N Engl J Med"},{"key":"408_CR39","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1182\/blood-2007-09-112052","volume":"111","author":"H Bonig","year":"2008","unstructured":"Bonig H et al. Increased numbers of circulating hematopoietic stem\/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood. 2008;111:3439\u201341.","journal-title":"Blood"},{"key":"408_CR40","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1212\/01.wnl.0000327671.91357.96","volume":"71","author":"M Krumbholz","year":"2008","unstructured":"Krumbholz M et al. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology. 2008;71:1350\u20134.","journal-title":"Neurology"},{"key":"408_CR41","doi-asserted-by":"publisher","first-page":"e1003014","DOI":"10.1371\/journal.ppat.1003014","volume":"8","author":"MR Perkins","year":"2012","unstructured":"Perkins MR et al. Changes in JC virus-specific T cell responses during natalizumab treatment and in natalizumab-associated progressive multifocal leukoencephalopathy. PLoS Pathog. 2012;8:e1003014.","journal-title":"PLoS Pathog"},{"key":"408_CR42","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/2042098612453849","volume":"3","author":"F Zaheer","year":"2012","unstructured":"\u2022 Zaheer F, Berger JR. Treatment related progressive multifocal leukoencephalopathy: current understanding and future steps. Ther Adv Drug Safety. 2012;3:227\u201339. Excellent recent overview of treatment of PML.","journal-title":"Ther Adv Drug Safety"},{"key":"408_CR43","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G et al. Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012;366:1870\u201380.","journal-title":"N Engl J Med"},{"key":"408_CR44","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","volume":"57","author":"P Lee","year":"2013","unstructured":"Lee P et al. A second-generation ELISA (STRATIFY JCV DxSelect) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. J Clin Virol. 2013;57:141\u20136.","journal-title":"J Clin Virol"},{"issue":"1","key":"408_CR45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.23893","volume":"74","author":"JR Berger","year":"2013","unstructured":"Berger JR et al. JC virus antibody status underestimates infection rates. Ann Neurol. 2013;74(1):84\u201390.","journal-title":"Ann Neurol"},{"issue":"10","key":"408_CR46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1212\/WNL.0b013e3182a352a6","volume":"81","author":"EO Major","year":"2013","unstructured":"Major EO, Douek DC. Risk factors for rare diseases can be risky to define: PML and natalizumab. Neurology. 2013;81(10):858\u20139.","journal-title":"Neurology"},{"key":"408_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"\u2022 Clifford DB et al. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010;9:438\u201346. Thorough overview of clinical presentation of PML.","journal-title":"Lancet Neurol"},{"key":"408_CR48","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/10428190902779257","volume":"50","author":"KR Carson","year":"2009","unstructured":"Carson KR, Bennett CL. Rituximab and progressive multi-focal leukoencephalopathy: the jury is deliberating. Leuk Lymphoma. 2009;50:323\u20134.","journal-title":"Leuk Lymphoma"},{"key":"408_CR49","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Berger JR et al. PML diagnostic criteria: consensus statement from the American Academy of Neurology Neuroinfectious Disease Section. Neurology. 2013;80:1430\u20138. Definitive AAN American Academy of Neurology consensus statement of PML diagnosis.","DOI":"10.1212\/WNL.0b013e31828c2fa1"},{"key":"408_CR50","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ana.23676","volume":"72","author":"TA Yousry","year":"2012","unstructured":"Yousry TA et al. Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol. 2012;72:779\u201387.","journal-title":"Ann Neurol"},{"key":"408_CR51","unstructured":"Biogen Idec. Natalizumab safety update. Available at: http:\/\/medinfo.biogenidec.com (accessed 20 August 2013)."}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-013-0408-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0408-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-013-0408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:16:15Z","timestamp":1744157775000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-013-0408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,18]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1007\/s11910-013-0408-6","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,18]]},"assertion":[{"value":"18 October 2013","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"408"}}